116 related articles for article (PubMed ID: 37890591)
1. PEGylated insulin loaded complexation hydrogels for protected oral delivery.
Coolich MK; Lanier OL; Cisneros E; Peppas NA
J Control Release; 2023 Dec; 364():216-226. PubMed ID: 37890591
[TBL] [Abstract][Full Text] [Related]
2. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models.
Wood KM; Stone GM; Peppas NA
Acta Biomater; 2010 Jan; 6(1):48-56. PubMed ID: 19481619
[TBL] [Abstract][Full Text] [Related]
3. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.
Wood KM; Stone GM; Peppas NA
Biomacromolecules; 2008 Apr; 9(4):1293-8. PubMed ID: 18330990
[TBL] [Abstract][Full Text] [Related]
4. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
Ichikawa H; Peppas NA
J Biomed Mater Res A; 2003 Nov; 67(2):609-17. PubMed ID: 14566804
[TBL] [Abstract][Full Text] [Related]
5. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.
Tuesca AD; Reiff C; Joseph JI; Lowman AM
Pharm Res; 2009 Mar; 26(3):727-39. PubMed ID: 19145407
[TBL] [Abstract][Full Text] [Related]
7. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
8. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
9. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
10. Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogel microcarriers for oral protein delivery.
O'Connor C; Steichen S; Peppas NA
J Biomed Mater Res A; 2017 May; 105(5):1243-1251. PubMed ID: 28177593
[TBL] [Abstract][Full Text] [Related]
11. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
[TBL] [Abstract][Full Text] [Related]
12. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
[TBL] [Abstract][Full Text] [Related]
13. Cellular evaluation of synthesized insulin/transferrin bioconjugates for oral insulin delivery using intelligent complexation hydrogels.
Shofner JP; Phillips MA; Peppas NA
Macromol Biosci; 2010 Mar; 10(3):299-306. PubMed ID: 20034125
[TBL] [Abstract][Full Text] [Related]
14. Development of a P((MAA-co-NVP)-g-EG) Hydrogel Platform for Oral Protein Delivery: Effects of Hydrogel Composition on Environmental Response and Protein Partitioning.
Steichen S; O'Connor C; Peppas NA
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27689827
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of insulin using pH-responsive complexation gels.
Lowman AM; Morishita M; Kajita M; Nagai T; Peppas NA
J Pharm Sci; 1999 Sep; 88(9):933-7. PubMed ID: 10479357
[TBL] [Abstract][Full Text] [Related]
16. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.
Kim B; Peppas NA
Int J Pharm; 2003 Nov; 266(1-2):29-37. PubMed ID: 14559391
[TBL] [Abstract][Full Text] [Related]
17. Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX.
Horava SD; Peppas NA
Ann Biomed Eng; 2016 Jun; 44(6):1970-82. PubMed ID: 26883955
[TBL] [Abstract][Full Text] [Related]
18. Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids.
Yamagata T; Morishita M; Kavimandan NJ; Nakamura K; Fukuoka Y; Takayama K; Peppas NA
J Control Release; 2006 May; 112(3):343-9. PubMed ID: 16631271
[TBL] [Abstract][Full Text] [Related]
19. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
Kavimandan NJ; Losi E; Peppas NA
Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
[TBL] [Abstract][Full Text] [Related]
20. Cellular evaluation of insulin transmucosal delivery.
López JE; Peppas NA
J Biomater Sci Polym Ed; 2004; 15(4):385-96. PubMed ID: 15212324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
